The estimated Net Worth of Angela Hwang is at least $6.59 million dollars as of 25 February 2023. Ms Hwang owns over 20,273 units of Pfizer stock worth over $1,321,086 and over the last 7 years she sold PFE stock worth over $1,298,032. In addition, she makes $3,971,014 as Group Pres of Biopharmaceuticals Group at Pfizer.
Ms has made over 9 trades of the Pfizer stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 20,273 units of PFE stock worth $464,049 on 25 February 2023.
The largest trade she's ever made was exercising 57,032 units of Pfizer stock on 22 February 2023 worth over $1,720,655. On average, Ms trades about 8,539 units every 63 days since 2018. As of 25 February 2023 she still owns at least 44,541 units of Pfizer stock.
You can see the complete history of Ms Hwang stock trades at the bottom of the page.
Angela Hwang is the Group Pres of Biopharmaceuticals Group at Pfizer.
As the Group Pres of Biopharmaceuticals Group of Pfizer, the total compensation of Ms Hwang at Pfizer is $3,971,014. There are 7 executives at Pfizer getting paid more, with Albert Bourla having the highest compensation of $17,929,000.
Ms Hwang is 55, she's been the Group Pres of Biopharmaceuticals Group of Pfizer since . There are 19 older and 7 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
Angela's mailing address filed with the SEC is 55 GLENLAKE PARKWAY, NE, , ATLANTA, GA, 30328.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read et James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: